https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/international-aids-conference
Adverse Events, Comorbidities, and HIV

International AIDS Conference

The Latest

Dual Maintenance Therapy With Dolutegravir + Rilpivirine Img

Dual Maintenance Therapy With Dolutegravir + Rilpivirine

In clinical trials called Sword 1 and Sword 2, researchers testing a combination of dolutegravir/rilpivirine (Juluca) found it to be effective and tolerable.

Higher Rates of Eye Complications in HIV-Positive People on ART Img

Higher Rates of Eye Complications in HIV-Positive People on ART

A prospective South African study looked at rates of optical complications and associations with HIV status and time on ART, and found conditions affecting the external eye, anterior chamber or posterior chamber, but not the neuro-ophthalmic segment,...

Tenofovir-Containing ART Reduces Bone Mineral Density in Breast-Feeding Women: Results From IMPAACT P1084s Img

Tenofovir-Containing ART Reduces Bone Mineral Density in Breast-Feeding Women: Results From IMPAACT P1084s

Tenofovir DF-containing ART decreases bone mineral density in HIV-positive, breast-feeding women, according to findings presented at the 8th International Workshop on HIV Paediatrics.

Beyond Cervical Cancer: Patterns and Treatment of Gynecologic Malignancies Among Women Living With HIV Img

Beyond Cervical Cancer: Patterns and Treatment of Gynecologic Malignancies Among Women Living With HIV

With HIV-positive women living longer, cancer epidemiologist Anne F. Rositch, Ph.D., looked at contemporary trends, patterns of disease, adherence to national care guidelines and barriers to treatment of non-HPV-associated gynecologic malignancies....

Promo Image

The Future of Hepatitis C Treatment

We now have a wide range of direct-acting antivirals that can cure hepatitis C. But what will the future of hepatitis C treatment look like? In a recent presentation, Jurgen K. Rockstroh, M.D., outlined what’s in store.

A Closer Look at Cancer Among People Living With HIV Img

A Closer Look at Cancer Among People Living With HIV

At a session at the 2016 International AIDS Conference, Benigno Rodríguez, M.D., M.Sc., FIDSA, summarized what researchers know about the risk of developing certain cancers among people in North America living with HIV.

What Do Vitamin D Levels at HIV Treatment Initiation Have to Do With CD4 Cell Count Recovery? Img

What Do Vitamin D Levels at HIV Treatment Initiation Have to Do With CD4 Cell Count Recovery?

Alison Abraham, Ph.D., discusses her study of whether vitamin D levels at initiation of antiretroviral therapy are associated with the post-initiation plateau and rate of rise of CD4 count.

Taking a Closer Look at Cancer Treatment Rates Among Elderly Adults Living With HIV Img

Taking a Closer Look at Cancer Treatment Rates Among Elderly Adults Living With HIV

Studies suggest that people who are HIV-positive are less likely to receive cancer treatment than those who are HIV-negative. Anne Rositch, Ph.D., discusses why this "HIV effect" might exist.

Bone Density Decreases More for Individuals Living With HIV in U.S. Study Img

Bone Density Decreases More for Individuals Living With HIV in U.S. Study

Bone mineral density (BMD) declined significantly more in antiretroviral-treated U.S. study participants with HIV than in age-similar HIV-negative adults over seven years of follow-up.

HPV, HIV and Cervical Cancer: Leveraging Synergies to Save Women's Lives Img

HPV, HIV and Cervical Cancer: Leveraging Synergies to Save Women's Lives

The burden that HIV places on women, particularly adolescent girls and young women from low- and middle-income countries, is compounded by the global burden of human papillomavirus (HPV) infection and cervical cancer.